If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea Antinori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 59 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Acquired Immunodeficiency Syndrome Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
CD4 Lymphocyte Count Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

  • 17235 Citations
  • 67 h-Index
  • 611 Article
  • 3 Letter
  • 2 Review article

A prospective randomized trial on abacavir/ lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

Mussini, C., Roncaglia, E., Borghi, V., Rusconi, S., Nozza, S., Cattelan, A. M., Segala, D., Bonfanti, P., Biagio, A. D., Barchi, E., Focà, E., Antoni, A. D., Bonora, S., Francisci, D., Limonta, S., Antinori, A., D’Ettorre, G. & Maggiolo, F., Jan 1 2019, In : PLoS One. 14, 9, p. 1-11 11 p., e0222650.

Research output: Contribution to journalArticle

Open Access
CD4 Lymphocyte Count
Pharmaceutical Preparations
9 Citations (Scopus)

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Wohl, D. A., Yazdanpanah, Y., Baumgarten, A., Clarke, A., Thompson, M. A., Brinson, C., Hagins, D., Ramgopal, M. N., Antinori, A., Wei, X., Acosta, R., Collins, S. E., Brainard, D. & Martin, H., Jun 1 2019, In : The Lancet HIV. 6, 6, p. e355-e363

Research output: Contribution to journalArticle

HIV Infections
lamivudine drug combination abacavir

Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study

Antinori, A., Rusconi, S., Gianotti, N., Bini, T., Mancusi, D. & Termini, R., Jan 1 2019, In : Drug Design, Development and Therapy. 13, p. 1667-1685 19 p.

Research output: Contribution to journalArticle

Open Access
Observational Studies
Blood Pressure
Anti-HIV Agents

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

Fabeni, L., Alteri, C., Berno, G., Scutari, R., Orchi, N., De Carli, G., Bertoli, A., Carioti, L., Gori, C., Forbici, F., Salpini, R., Vergori, A., Gagliardini, R., Cicalini, S., Mondi, A., Pinnetti, C., Mazzuti, L., Turriziani, O., Colafigli, M., Borghi, V. & 10 others, Montella, F., Pennica, A., Lichtner, M., Girardi, E., Andreoni, M., Mussini, C., Antinori, A., Ceccherini-Silberstein, F., Perno, C. F. & Santoro, M. M., Jan 1 2019, In : Sexually Transmitted Infections. p. 1-7 7 p.

Research output: Contribution to journalArticle

CD4 Lymphocyte Count
Logistic Models
Viral Load

Defining cerebrospinal fluid HIV RNA escape: Editorial review AIDS

Winston, A., Antinori, A., Cinque, P., Fox, H. S., Gisslen, M., Henrich, T. J., Letendre, S., Persaud, D., Price, R. W. & Spudich, S., Dec 1 2019, In : AIDS. 33, Suppl 2, p. S107-S111 5 p.

Research output: Contribution to journalReview article